Wnt/&bgr;-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|10|7|716-727

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.10, Iss.7, 2010-11, pp. : 716-727

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New treatment options for chronic lymphocytic leukemia

By Delgado Julio   Baumann Tycho   Santacruz Rodrigo   Montserrat Emili  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. : 823-832

Informa Healthcare

Access to resources Recommend Favorite

Signaling Mechanisms Underlying A&bgr; Toxicity: Potential Therapeutic Targets for Alzheimer's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 3, 2006-06 ,pp. : 355-361

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Signaling Pathways in Chronic Lymphocytic Leukemia

By  

Current Cancer Drug Targets, Vol. 16, Iss. 8, 2016-09 ,pp. : 669-688

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple Metamorphoses of CD38 from Prognostic Marker to Disease Modifier to Therapeutic Target in Chronic Lymphocytic Leukemia

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 23, 2013-12 ,pp. : 2955-2964

Bentham Science Publishers

Access to resources Recommend Favorite

Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge

By  

Current Cancer Drug Targets, Vol. 16, Iss. 8, 2016-09 ,pp. : 701-709

Bentham Science Publishers

Access to resources Recommend Favorite